<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02979626</url>
  </required_header>
  <id_info>
    <org_study_id>16-1785</org_study_id>
    <nct_id>NCT02979626</nct_id>
  </id_info>
  <brief_title>Evaluation of Moderate to Severe Influenza Outcomes in Children</brief_title>
  <acronym>M2SFlu</acronym>
  <official_title>Evaluation of Moderate to Severe Influenza Disease in Children 6 Months to 8 Years in Colorado</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a moderate-severe endpoints (including high
      fever, lower respiratory tract disease, acute otitis media, or serious extra-pulmonary
      complications are predictive of hospitalization, intensive care admission, antibiotic use and
      other complications in children under 8 years of age.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective observational study aims to determine the risk difference of hospitalization
      due to moderate to severe influenza compared with mild influenza among children aged 6 months
      to 8 years who are evaluated at Children's Hospital Colorado emergency department and urgent
      care during the 2016-2017 influenza season. In addition, it intends to evaluate the risk
      difference for other health outcomes such as ICU admission, antibiotic and antiviral use,
      caregiver and child absenteeism and recurrent (&gt;1) healthcare visits, and to compare the
      healthcare costs associated with management of moderate to severe versus mild influenza in
      children. Children presenting to Children's Hospital Colorado ED and urgent care affiliated
      sites (North Campus urgent care) with an influenza-like illness from December 2016 to April
      2017, during the 2016-2017 influenza season will be eligible for the study. Once enrolled in
      the study, we will collect respiratory samples (nasal swab specimens) for influenza testing
      by PCR, sociodemographic and clinical data including variables of interest outlined above,
      and follow the clinical outcome of these children for 14 days after their initial
      presentation. Some of the variables of interest we will collect are shown below.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 4, 2017</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hospitalization</measure>
    <time_frame>0-14 days</time_frame>
    <description>Hospitalization within 14 days of influenza infection diagnosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU admission</measure>
    <time_frame>0-14 days</time_frame>
    <description>Admission to the intensive care unit after influenza diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antiviral use</measure>
    <time_frame>0-14 days</time_frame>
    <description>Antiviral use in children presenting to the ED or urgent care with influenza</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antibiotic use</measure>
    <time_frame>0-14 days</time_frame>
    <description>Antibiotic use in children presenting to the ED or urgent care with influenza</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrent visits</measure>
    <time_frame>0-14 days</time_frame>
    <description>Recurrent visits to the ED or healthcare provider in children presenting to the ED or urgent care with influenza</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>School absenteeism</measure>
    <time_frame>0-14 days</time_frame>
    <description>Absenteeism from school or daycare in patients presenting to the ED or urgent care with influenza</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Work absenteeism</measure>
    <time_frame>0-14 days</time_frame>
    <description>Absenteeism from work in caregivers of children presenting to the ED or urgent care with influenza</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Injectable influenza vaccine (IIV) Hospitalization</measure>
    <time_frame>0-14 days</time_frame>
    <description>Hospitalization among children who received IIV presenting to the ED or urgent care with influenza.</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1600</enrollment>
  <condition>Influenza</condition>
  <condition>Otitis Media</condition>
  <condition>Lower Resp Tract Infection</condition>
  <condition>Encephalitic Infection</condition>
  <condition>Myositis Viral</condition>
  <condition>Fever</condition>
  <arm_group>
    <arm_group_label>Moderate-to-severe Influenza</arm_group_label>
    <description>Children 6 weeks to 8 years of age with influenza-like illness and one of the following:
Fever &gt;39
Lower respiratory tract infection
Acute otitis media
Serious extra-pulmonary manifestations (myositis, encephalitis)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mild Influenza</arm_group_label>
    <description>Children 6 weeks to 8 years of age with influenza-like illness (ILI) without the criteria for moderate-to-severe disease (above)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Respiratory nasal swab</intervention_name>
    <description>Nasal swabs will be obtained for testing by the study nurses. If a respiratory sample has already been collected as part of routine clinical care, this will replace the study collection, and no additional testing will be required.</description>
    <arm_group_label>Moderate-to-severe Influenza</arm_group_label>
    <arm_group_label>Mild Influenza</arm_group_label>
    <other_name>Nasal swab</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Respiratory swab samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Children 6 months to 8 years of age and younger seeking evaluation and management of
        influenza-like illness (ILI) at any of the study sites will be eligible for participation
        in the study. The study will commence during the influenza season as determined by the
        department of microbiology and epidemiology at CHCO (the influenza season commences when
        there are 3 positive influenza PCR tests within a week), approximately from December 1,
        2016 to April 30, 2017.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 6 months to &lt; 8 years

          -  Presentation to one of the study sites with signs and symptoms of influenza-like
             illness (temperature of &gt;37.8‚Å∞C and at least one of the following: cough, sore throat,
             runny nose or nasal congestion)

          -  Parents or guardians agreeing and consenting to medical information release,
             respiratory specimen collection and testing, email/phone call follow up and collection
             of leftover blood samples obtained during routine clinical care

          -  Patients seen during the 2016-2017 influenza season

        Exclusion Criteria:

          -  Respiratory symptom duration &gt; 14 days

          -  Nurse only visit

          -  Enrollment in the study within prior 14 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edwin J Asturias, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Suchitra Rao, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Molly Lamb, PhD</last_name>
    <phone>303-724-4433</phone>
    <email>molly.lamb@ucdenver.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kathleen Grice</last_name>
    <phone>303-724-3285</phone>
    <email>kathleen.grice@childrenscolorado.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Grice</last_name>
      <phone>303-724-3285</phone>
      <email>kathleen.grice@childrenscolorado.org</email>
    </contact>
    <investigator>
      <last_name>Suchitra Rao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rakesh Mistry, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital North Campus Urgent Care</name>
      <address>
        <city>Broomfield</city>
        <state>Colorado</state>
        <zip>80023</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Grice</last_name>
      <phone>303-724-3285</phone>
      <email>kathleen.grice@childrenscolorado.org</email>
    </contact>
    <contact_backup>
      <last_name>Reagan Miller</last_name>
      <phone>303-724-3285</phone>
      <email>reagan.miller@childrenscolorado.org</email>
    </contact_backup>
    <investigator>
      <last_name>Suchitra Rao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Wilkes JJ, Leckerman KH, Coffin SE, Keren R, Metjian TA, Hodinka RL, Zaoutis TE. Use of antibiotics in children hospitalized with community-acquired, laboratory-confirmed influenza. J Pediatr. 2009 Mar;154(3):447-9. doi: 10.1016/j.jpeds.2008.09.026.</citation>
    <PMID>19874761</PMID>
  </reference>
  <reference>
    <citation>Coffin SE, Zaoutis TE, Rosenquist AB, Heydon K, Herrera G, Bridges CB, Watson B, Localio R, Hodinka RL, Keren R. Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics. 2007 Apr;119(4):740-8.</citation>
    <PMID>17403845</PMID>
  </reference>
  <reference>
    <citation>Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, Black S, Shinefield H, Fukuda K. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000 Jan 27;342(4):232-9.</citation>
    <PMID>10648764</PMID>
  </reference>
  <reference>
    <citation>Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000 Jan 27;342(4):225-31.</citation>
    <PMID>10648763</PMID>
  </reference>
  <reference>
    <citation>Salo H, Kilpi T, Sintonen H, Linna M, Peltola V, Heikkinen T. Cost-effectiveness of influenza vaccination of healthy children. Vaccine. 2006 Jun 5;24(23):4934-41. Epub 2006 Apr 7.</citation>
    <PMID>16678945</PMID>
  </reference>
  <reference>
    <citation>Ferdinands JM, Olsho LE, Agan AA, Bhat N, Sullivan RM, Hall M, Mourani PM, Thompson M, Randolph AG; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012. J Infect Dis. 2014 Sep 1;210(5):674-83. doi: 10.1093/infdis/jiu185. Epub 2014 Mar 26.</citation>
    <PMID>24676207</PMID>
  </reference>
  <reference>
    <citation>Heikkinen T, Silvennoinen H, Heinonen S, Vuorinen T. Clinical and socioeconomic impact of moderate-to-severe versus mild influenza in children. Eur J Clin Microbiol Infect Dis. 2016 Jul;35(7):1107-13. doi: 10.1007/s10096-016-2641-9. Epub 2016 Apr 16.</citation>
    <PMID>27086364</PMID>
  </reference>
  <reference>
    <citation>Jain VK, Rivera L, Zaman K, Espos RA Jr, Sirivichayakul C, Quiambao BP, Rivera-Medina DM, Kerdpanich P, Ceyhan M, Dinleyici EC, Cravioto A, Yunus M, Chanthavanich P, Limkittikul K, Kurugol Z, Alhan E, Caplanusi A, Durviaux S, Boutet P, Ofori-Anyinam O, Chandrasekaran V, Dbaibo G, Innis BL. Vaccine for prevention of mild and moderate-to-severe influenza in children. N Engl J Med. 2013 Dec 26;369(26):2481-91. doi: 10.1056/NEJMoa1215817. Epub 2013 Dec 11.</citation>
    <PMID>24328444</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2016</study_first_submitted>
  <study_first_submitted_qc>November 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2016</study_first_posted>
  <last_update_submitted>January 12, 2018</last_update_submitted>
  <last_update_submitted_qc>January 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hospitalization</keyword>
  <keyword>intensive care unit</keyword>
  <keyword>school absenteeism</keyword>
  <keyword>work absenteeism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Influenza, Human</mesh_term>
    <mesh_term>Otitis Media</mesh_term>
    <mesh_term>Myositis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

